Caris Life Sciences CAI
NASDAQ CAI
$30.71 +0.15 (+0.49%)
At close: Oct 19, 2026 · 4:00 PM EDT

Caris Life Sciences (CAI) EV to EBITDA (2025 - 2026)

Updated

Caris Life Sciences' (CAI) EV to EBITDA was 24.37 for Q2 2026, down 25.6% from the prior quarter.

Analysis

Caris Life Sciences (CAI) EV to EBITDA (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Caris Life Sciences' EV to EBITDA came in at 10.70; for FY2025, it came in at 54.79.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 Caris Life Sciences 8.68 Bn 5.51 Bn 179.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.56
Mar 31, 2026 29.69
Dec 31, 2025 46.09
API Access

Caris Life Sciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CAI&period=max&api_key=YOUR_API_KEY